Study shows risk for emergently treated hypocalcemia with denosumab rises with CKD stage

1 week ago 2

For patients with chronic kidney disease (CKD), the risk for emergently treated hypocalcemia with denosumab increases with worsening CKD stage, according to a study published online Nov. 19 in the Annals of Internal Medicine.